# ROCKET PHARMACEUTICALS, INC. (RCKT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ROCKET PHARMACEUTICALS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RCKT/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-076551 (https://www.sec.gov/Archives/edgar/data/1281895/000119312526076551/rckt-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RCKT/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-029002 (https://www.sec.gov/Archives/edgar/data/1281895/000095017025029002/rckt-20241231.htm)
- [FY 2023 MD&A](/company/RCKT/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-021096 (https://www.sec.gov/Archives/edgar/data/1281895/000095017024021096/rckt-20231231.htm)
- [FY 2022 MD&A](/company/RCKT/mda/fy2022/): filed 2023-02-28; accession 0001140361-23-009252 (https://www.sec.gov/Archives/edgar/data/1281895/000114036123009252/brhc10048995_10k.htm)
- [FY 2021 MD&A](/company/RCKT/mda/fy2021/): filed 2022-02-28; accession 0001140361-22-007036 (https://www.sec.gov/Archives/edgar/data/1281895/000114036122007036/brhc10034550_10k.htm)

Back to /company/RCKT/